Due to the current coronavirus (COVID-19) situation, Hamad Bin Khalifa University (HBKU) events will be postponed or canceled until the end of June 2020 and classes have been suspended on campus until further notice.
With a remote working approach in place, HBKU remains fully committed to ensuring educational continuity through its online learning platforms.
For further updates please visit: COVID-19
Share
Research
Research Centers
The QBRI research centers are composed of multidisciplinary teams focused on certain scientific programs and supported by powerful platforms due to the enormous biological complexity of the research studies. In keeping with Qatar National Health Strategy 2018-2022, QBRI will establish and operate three centers of scientific excellence to better synergize and optimize the R&D investment. As we build QBRI infrastructure, we mandate excellence at all levels in our operations, facilities and partnerships with the best local and international biomedical research institutions.
Consistent with its mission to develop and promote translational biomedical research, encourage national and international collaborations and increase knowledge sharing; three research centers, six core advanced technology platforms and three enabling platforms are to be created over a period of five years. QBRI’s established research centers are :
-
NEUROLOGICAL
DISORDERS CENTERThe NDRC is a pioneer neuroscience center in Qatar and the region that aims to study neurological disorders of significant importance.
-
DIABETES CENTER
This center promotes innovative research on type 1 and type 2 diabetes and related metabolic disorders.
-
CANCER RESEARCH CENTER
The major focus of the Cancer Research Center is cancer immunology and immunotherapy.
-
INTERDISCIPLINARY GRANTS PROGRAM
This initiative is to encourage QBRI’s researchers in tackling common scientific challenges to work together and stimulate biomedical research.